Serotonin syndrome
- 1 February 1995
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 45 (2) , 219-223
- https://doi.org/10.1212/wnl.45.2.219
Abstract
Article abstract—We describe a patient treated with trazodone, isocarboxazid, and methylphenidate hydrochloride who developed confusion, agitation, poor concentration, rigidity, myoclonus, involuntary movements, orthostatic hypotension, and hyperreflexia. CK was normal, and the syndrome resolved spontaneously over 12 hours. The serotonin syndrome occurs following the use of serotomimetic agents (serotonin reuptake inhibitors, tricyclic and tetracyclic an-tidepressants, tryptophan, 3,4–methylenedioxy-methamphetamine, dextromethorphan, meperidine, S-adenosylmethio-nine) alone or in combination with monoamine oxidase inhibitors. It is characterized by various combinations of myoclonus, rigidity, hyperreflexia, shivering, confusion, agitation, restlessness, coma, autonomic instability, low-grade fever, nausea, diarrhea, diaphoresis, flushing, and, rarely, rhabdomyolysis and death.Keywords
This publication has 0 references indexed in Scilit: